GSK added Ojjaara to its portfolio through the acquisition of Sierra in 2022. Credit: Magda Wygralak via Shutterstock. Health ...

The KSE-100 index of Pakistan Stock Exchange (PSX) lost on Tuesday more than 400 points, weighed down by institutional profit ...

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...

having served as head of international and commercial roles at Mirati Therapeutics (acquired by Bristol-Myers Squibb), Agios Pharmaceuticals (oncology business acquired by Servier) and at TESARO ...

The Pakistani Rupee has slipped against the US Dollar, with the exchange rate showing a slight decline in intra-day trading. The USD is trading at Rs277.80 in in the interbank market during intra-day ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...

Saudi Arabia Pharmaceutical Drugs Market is estimated to be valued at US$ 12.60 billion in 2024 and is expected to exhibit a CAGR of 7.6% by 2031 BURLINGAME, CA, UNITED STATES, November 12, 2024 ...

DelveInsight's Glucose Syrup Market Insights report provides the current and forecast market analysis, individual leading ...

Marksans Pharma Limited was formerly incorporated as Tasc Pharmaceuticals Limited in April 1982. Pursuant to the Scheme of Amalgamation name of the Company was changed from Tasc Pharmaceuticals ...